Ectopic	O
localization	O
of	O
mitochondrial	B-Cellular_component
ATP	O
synthase	O
:	O
a	O
target	O
for	O
anti	O
-	O
angiogenesis	O
intervention	O
?	O

A	O
receptor	O
for	O
angiostatin	O
was	O
identified	O
on	O
the	O
surface	B-Cellular_component
of	O
endothelial	B-Cell
cells	I-Cell
as	O
F	O
(	O
1	O
)	O
-	O
F	O
(	O
0	O
)	O
ATP	O
synthase	O
(	O
Moser	O
et	O
al	O
.	O
,	O
1999	O
)	O
.	O

Proc	O
.	O

Natl	O
.	O

Acad	O
.	O

Sci	O
.	O

U	O
.	O
S	O
.	O
A	O
.	O

96	O
,	O
2811	O
-	O
2816	O
.	O

This	O
ectopic	O
ATP	O
synthase	O
catalyzes	O
ATP	O
synthesis	O
and	O
is	O
inhibited	O
by	O
angiostatin	O
over	O
a	O
wide	O
pH	O
range	O
.	O

Endothelial	B-Cell
cells	I-Cell
grown	O
at	O
normal	O
pH	O
suffer	O
no	O
ill	O
effects	O
from	O
this	O
angiostatin	O
-	O
mediated	O
inhibition	O
of	O
ATP	O
synthase	O
,	O
whereas	O
endothelial	B-Cell
cells	I-Cell
grown	O
at	O
low	O
,	O
tumor	B-Cancer
-	O
like	O
extracellular	B-Immaterial_anatomical_entity
pH	O
cannot	O
maintain	O
a	O
normal	O
intracellular	B-Immaterial_anatomical_entity
pH	O
and	O
die	O
.	O

Angiostatin	O
inhibits	O
both	O
ATP	O
synthesis	O
and	O
ATP	O
hydrolysis	O
(	O
Moser	O
et	O
al	O
.	O
,	O
2001	O
)	O
and	O
interferes	O
with	O
intracellular	B-Immaterial_anatomical_entity
pH	O
regulation	O
(	O
Wahl	O
and	O
Grant	O
,	O
2002	O
;	O
Wahl	O
et	O
al	O
.	O
,	O
2002	O
)	O
.	O

Although	O
angiostatin	O
administered	O
intravenously	B-Immaterial_anatomical_entity
is	O
cleared	O
from	O
the	O
circulation	O
in	O
a	O
matter	O
of	O
minutes	O
,	O
angiostatin	O
-	O
mimetics	O
that	O
are	O
more	O
stable	O
have	O
potential	O
for	O
clinical	O
application	O
.	O

An	O
angiostatin	O
-	O
mimetic	O
activity	O
has	O
recently	O
been	O
observed	O
using	O
a	O
polyclonal	O
antibody	O
against	O
the	O
beta	O
catalytic	O
subunit	O
of	O
ATP	O
synthase	O
.	O

In	O
order	O
to	O
explore	O
the	O
mechanism	O
of	O
action	O
of	O
angiostatin	O
and	O
its	O
mimetics	O
,	O
further	O
work	O
needs	O
to	O
be	O
done	O
to	O
evaluate	O
clinical	O
applicability	O
,	O
specificity	O
,	O
and	O
contraindications	O
for	O
this	O
class	O
of	O
therapeutics	O
.	O

